Nascent Biotech, developer of Pritumumab (PTB), a monoclonal antibody shown promise in the treatment of brain cancer, has partnered with BioTools Inc (Jupiter, FL) to clearly define PTB’s  higher order molecular structure (HOS) .

BioTools announces a collaboration with Schrödinger aimed at accelerating the discovery and development of chiral small molecule therapeutics

BioTools and Liverpool ChiroChem announce a collaboration aimed at accelerating the discovery of novel, stereo-defined, enantioenriched compounds.


BioTools, Inc. co-founder and President receives University of Illinois Lifetime Achievement Award!


Press Release

Vibrational circular dichroism (VCD), an important analytical method for determining the absolute configuration (AC) and purity of chiral molecules, has been published as a new “standard method” in the U. S. Pharmacopeia (USP 39-NF34, Chapters 782 and 1782). The chapters became official on December 1st, 2016.
BioTools celebrates growth of VCD at Chirality Meeting!

BioTools partners with Chiral Technologies!

Press Release

BioTools together with Ghent University and University of Antwerp are pleased to announce the formation of The European Centre for Chirality (EC2).

Press Release

BioTools, Inc. celebrated its 10-year anniversary in 2010. From the start, we dared to be unique, innovative, and customer- driven and commercialized two groundbreaking techniques – VCD and ROA.

BioTools announces establishment of BioTools Europe.

Press Release

Scroll to Top